Brianna L. Goldenstein, BS
Affiliations: | Pharmacology, Physiology, and Therapeutics | University of North Dakota School of Medicine and Health Sciences |
Area:
adrenergic receptors, adult neurogenesisGoogle:
"Brianna Goldenstein"Mean distance: 15.89 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Van A. Doze | grad student | 2014 | University of North Dakota | |
| (Role of the alpha1A-adrenergic receptor in synaptic plasticity, cognition & neurogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Biggane JP, Xu K, Goldenstein BL, et al. (2022) Pharmacological characterization of the α-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency. Journal of Receptor and Signal Transduction Research. 1-8 |
| Doze VA, Papay RS, Goldenstein BL, et al. (2011) Long-term α1A-adrenergic receptor stimulation improves synaptic plasticity, cognitive function, mood, and longevity. Molecular Pharmacology. 80: 747-58 |
| Goldenstein BL, Nelson BW, Xu K, et al. (2009) Regulator of G protein signaling protein suppression of Galphao protein-mediated alpha2A adrenergic receptor inhibition of mouse hippocampal CA3 epileptiform activity. Molecular Pharmacology. 75: 1222-30 |
| Luger E, Davis K, Goldenstein B, et al. (2008) Alpha2A adrenergic receptor‐mediated inhibition of mouse hippocampal CA3 network activity The Faseb Journal. 22: 98-98 |
| Jurgens CW, Hammad HM, Lichter JA, et al. (2007) Alpha2A adrenergic receptor activation inhibits epileptiform activity in the rat hippocampal CA3 region. Molecular Pharmacology. 71: 1572-81 |